Varian Users Achieve Key Milestones in Adoption of HyperSight Imaging Solution
The company celebrates key milestones as its users continue to adopt the new HyperSight imaging solution on the Ethos and Halcyon radiotherapy systems
Stay updated with breaking news from Investigational Testing Authorization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The company celebrates key milestones as its users continue to adopt the new HyperSight imaging solution on the Ethos and Halcyon radiotherapy systems
/PRNewswire/ -- Varian, a Siemens Healthineers company, today shared two key milestones as its users continue to adopt the new HyperSight™ imaging solution on...
HALIFAX, NS / ACCESSWIRE / March 14, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) provides an update on its progress to achieve regulatory approval in Canada for its Reveal® TP (Syphilis) antibody test.
- Medicines and Healthcare products Regulatory Agency of the United Kingdom approves clinical trial in squamous cell carcinoma of the vulva at Addenbrookes...
HALIFAX, Nova Scotia, Feb. 04, 2022 -- Today, MedMira Inc. provides a pre-Annual General Meeting update on its regulatory and product development progress. This includes its COVID-19 and its... | February 4, 2022